Adbiotech

179530 · KOSDAQ · Health Care · SMALL CAP

Material event report (decision to sell own convertible bonds)

Capital raise(Material event report (decision to sell own convertible bonds))· FILED 2026-03-27· RCEPT 20260327001668

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-03) →

About this filing

The company is reselling convertible (or similar) bonds it had bought back, which brings their conversion rights back into the market.

Why companies file it: Resale of treasury bonds is disclosed because it can add future share supply.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-03-27, Material event report (decision to sell own convertible bonds)
SourceDART rcept 20260327001668 → open original filing

Versions of this filing

  1. 2026-03-27Original (this page)
  2. 2026-05-12Amendment 1
  3. 2026-07-03Amendment 2
  4. 2026-07-30Amendment 3
  5. 2026-09-03Amendment 4

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-27 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).